4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-22-000104
Chief Medical Officer gave up 2,783 shares (to pay taxes)
- Chief Medical Officer acquired 9,375 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Gheuens Sarah Chief Medical Officer | 2022-12-23 | Option exercise | +9,375 | 18,388 | D: show line 1 in the form | ||
| Gheuens Sarah Chief Medical Officer | 2022-12-28 | Shares withheld for taxes | −2,783 | $28.48 | $79,260 | 15,605 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Gheuens Sarah Chief Medical Officer | 2022-12-23 | Option exercise · Restricted stock units | −9,375 | 0 | D: show line 3 in the form |
Loading xslF345X03/wf-form4_167226148971361.xml…